Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

1.1K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

5.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Association of maternal serum copper during early pregnancy with the risk of spontaneous preterm birth: A nested case-control study in China.

Environment international·2018
Same author

Automatic Assessment of Full Left Ventricular Coverage in Cardiac Cine Magnetic Resonance Imaging with Fisher Discriminative 3D CNN.

IEEE transactions on bio-medical engineering·2018
Same author

Diphenyl Ethers from a Marine-Derived <i>Aspergillus sydowii</i>.

Marine drugs·2018
Same author

In situ determination of trace elements in melt inclusions using laser ablation inductively coupled plasma sector field mass spectrometry.

Rapid communications in mass spectrometry : RCM·2018
Same author

A genetic variant in LINGO2 contributes to the risk of gestational diabetes mellitus in a Chinese population.

Journal of cellular physiology·2018
Same author

Gap Activity TOward Rags 1 variants in Chinese people with sporadic drug-resistant focal epilepsy.

Acta neurologica Scandinavica·2018

関連する実験動画

Updated: Sep 10, 2025

Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

895

パーキンソン病における認知機能に対する運動様式と用量の組み合わせの効果:ベイジアン用量反応体系的レビューとメタ解析

Shang Huang1, Le Zhang2

  • 1Jiangsu University, Zhenjiang, China.

Archives of gerontology and geriatrics
|August 23, 2025
PubMed
まとめ

パーキンソン病 (PD) の患者にとって,認知改善のための最も効果的な運動量は,週あたり約890MET·minで,週あたり500-1000MET·minの間で利益が見られます. マルチコンポーネントと 心と体のトレーニングが 最も効果的です

キーワード:
認知機能投与量-反応関係運動非薬学的介入パーキンソン病

さらに関連する動画

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
10:19

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease

Published on: August 22, 2014

14.3K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

関連する実験動画

Last Updated: Sep 10, 2025

Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

895
Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
10:19

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease

Published on: August 22, 2014

14.3K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

科学分野:

  • 神経科学
  • 運動 生理学
  • ゲロントロジー

背景:

  • パーキンソン病 (PD) は認知機能に大きく影響します
  • 非薬学的介入,特に運動はPDの症状の管理に不可欠です.
  • 認知機能の改善に最適な運動戦略は 明らかになっていない.

研究 の 目的:

  • パーキンソン病 (PD) の認知機能を改善するための最も効果的な運動方法を決定する.
  • PD患者の認知機能に最適な運動用量範囲を特定する.
  • PDの運動介入のための用量反応モデルを開発する.

主な方法:

  • ランダム化制御試験 (RCT) で1,256人のPD患者を対象とした33件の体系的レビューとベイジアン用量反応ネットワークのメタ解析.
  • MET·min/weekを用いた標準化された運動用量であり,GRADEフレームワークを用いて評価された.
  • 9つの運動様式で 非線形認知効果をモデル化しました

主要な成果:

  • 運動用量と認知的な結果の間には反転したU形の関係があり,ピークは約890MET/min/週です.
  • PDの認知改善のための最適な用量範囲は500〜1000MET/min/週です.
  • マルチコンポーネントトレーニングとマインド・ボディ・エクササイズが最も一貫した認知効果を示した. 仮想現実とエアロビックウォーキングは特定の効果を示したが,サイクリング,ダンス,レジスタンストレーニングは一貫した効果を示さなかった.

結論:

  • この研究は,パーキンソン病 (PD) の認知強化のための最初の用量モードレスポンスモデルを提供します.
  • 発見はPDの認知健康に 合わせた精度に基づく運動介入を 支持しています
  • この結果は,他の神経変性疾患における非薬理学的戦略に潜在的影響を及ぼします.